MoneyWorks4Me

Orchid Pharma informs about proceedings of the EGM

30 Jun 2021 Evaluate

In accordance with Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Orchid Pharma has informed that it has enclosed the Proceedings of the Extraordinary General Meeting (EGM) of the Company held on June 29, 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1847.95
Dr. Reddys Labs. 1149.30
Cipla 1360.50
Lupin 2046.50
Zydus Lifesciences 1108.45
View more..